Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00845884

Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer

A Phase I/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Patients With Advanced Gastric Cancer

Sponsor: Rabin Medical Center

Conditions Advanced Gastric Cancer

Interventions Docetaxel, Cisplatin, Capecitabine, Bevacizumab

Updated 5 times since 2017 Last updated: Feb 16, 2009 Started: Feb 28, 2009 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Advanced Gastric Cancer, this trial is ongoing. The trial is conducted by Rabin Medical Center and has accumulated 5 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rabin Medical Center

Data source: Rabin Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Petah Tikva, Israel